Guest guest Posted January 24, 2006 Report Share Posted January 24, 2006 Oops, just found this on a goggle news search. Looks like xolair trial for peanut allergy is halted. Too bad for anyone allergic to peanuts. I could wish some really nasty things on Genetech and Novartis, but this is not the place. http://www.truthabouttrade.org/article.asp? id=5071 > > to doubt, comes from the Wall Street Journal > http://www.karlloren.com/healthinsurance/p43.htm > The U.S. biotech giant Genentech Inc. and Swiss drug maker Novartis AG > insisted that Tanox kill TNX-901 in favor of a Genentech drug called > Xolair that has yet to prove effective against peanut allergy. When > Tanox refused, its partners took it to court. The ensuing legal fight > to kill TNX-901 spanned five years and consumed well over $100 million > in legal fees. > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 24, 2006 Report Share Posted January 24, 2006 Guess I the links I am posting are not formatting right with this board setup, here it is again http://www.truthabouttrade.org/article.asp?id=5071 > > > > to doubt, comes from the Wall Street Journal > > http://www.karlloren.com/healthinsurance/p43.htm > > The U.S. biotech giant Genentech Inc. and Swiss drug maker Novartis > AG > > insisted that Tanox kill TNX-901 in favor of a Genentech drug called > > Xolair that has yet to prove effective against peanut allergy. When > > Tanox refused, its partners took it to court. The ensuing legal fight > > to kill TNX-901 spanned five years and consumed well over $100 > million > > in legal fees. > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.